Sign in

CIK 0001420565

  • Non-accelerated filer
  • Smaller reporting company

Rein Therapeutics, Inc.

Sign in to watch
Ticker
RNTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
134196017
Phone
+1 737-802-1989
Business address
12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
Former names
Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-07-25 Gallagher Brian M. Jr. Director Grant or award · Stock Option (right to buy) +20,000 20,000
2017-07-05 Gallagher Brian M. Jr. Director Conversion +1,158,186 1,158,186
2017-07-05 Gallagher Brian M. Jr. Director Purchase +273,333 $15.00 $4.1M 1,431,519
2017-07-05 Gallagher Brian M. Jr. Director Conversion · Series D Preferred Stock −6,781,770 0
2017-07-05 Gallagher Brian M. Jr. Director Conversion · Series E-2 Preferred Stock −1,471,551 0
2017-07-05 Gallagher Brian M. Jr. Director Conversion · Series E-3 Preferred Stock −1,276,389 0
2017-07-05 Gallagher Brian M. Jr. Director Conversion · Series F Preferred Stock −1,979,188 0

Page 1 of 1 · 7 trades